tradingkey.logo

SelectQuote Inc

SLQT
1.100USD
+0.070+6.80%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
193.90MMarktkapitalisierung
10.13KGV TTM

SelectQuote Inc

1.100
+0.070+6.80%

mehr Informationen über SelectQuote Inc Unternehmen

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises the SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expense, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.

SelectQuote Inc Informationen

BörsenkürzelSLQT
Name des UnternehmensSelectQuote Inc
IPO-datumMay 21, 2020
CEODanker (Timothy Robert)
Anzahl der mitarbeiter1181
WertpapierartOrdinary Share
GeschäftsjahresendeMay 21
Addresse6800 West 115Th Street
StadtOVERLAND PARK
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl66211
Telefon19132741994
Websitehttps://ir.selectquote.com/investor-home/default.aspx
BörsenkürzelSLQT
IPO-datumMay 21, 2020
CEODanker (Timothy Robert)

Führungskräfte von SelectQuote Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Robert Clay (Bob) Grant
Mr. Robert Clay (Bob) Grant
President
President
4.32M
--
Mr. Timothy Robert (Tim) Danker
Mr. Timothy Robert (Tim) Danker
Chief Executive Officer, Director
Chief Executive Officer, Director
2.63M
--
Ms. Denise L. Devine, CPA
Ms. Denise L. Devine, CPA
Independent Director
Independent Director
371.21K
+52631.00%
Dr. Kavita K. Patel, M.D.
Dr. Kavita K. Patel, M.D.
Independent Director
Independent Director
363.21K
+52631.00%
Mr. Ryan Moore Clement
Mr. Ryan Moore Clement
Chief Financial Officer
Chief Financial Officer
304.70K
--
Ms. Sarah Anderson
Ms. Sarah Anderson
Executive Vice President - Pharmacy Services
Executive Vice President - Pharmacy Services
51.63K
+44106.00%
Mr. Donald L. Hawks, III
Mr. Donald L. Hawks, III
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Earl H. (Trace) Devanny, III
Mr. Earl H. (Trace) Devanny, III
Independent Director
Independent Director
--
--
Mr. Raymond F. Weldon
Mr. Raymond F. Weldon
Independent Director
Independent Director
--
--
Mr. William Thomas Grant, III
Mr. William Thomas Grant, III
Chief Operating Officer
Chief Operating Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Robert Clay (Bob) Grant
Mr. Robert Clay (Bob) Grant
President
President
4.32M
--
Mr. Timothy Robert (Tim) Danker
Mr. Timothy Robert (Tim) Danker
Chief Executive Officer, Director
Chief Executive Officer, Director
2.63M
--
Ms. Denise L. Devine, CPA
Ms. Denise L. Devine, CPA
Independent Director
Independent Director
371.21K
+52631.00%
Dr. Kavita K. Patel, M.D.
Dr. Kavita K. Patel, M.D.
Independent Director
Independent Director
363.21K
+52631.00%
Mr. Ryan Moore Clement
Mr. Ryan Moore Clement
Chief Financial Officer
Chief Financial Officer
304.70K
--
Ms. Sarah Anderson
Ms. Sarah Anderson
Executive Vice President - Pharmacy Services
Executive Vice President - Pharmacy Services
51.63K
+44106.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Pharmacy revenue
218.54M
66.46%
Commission
94.97M
28.88%
Production bonus and other revenue
15.30M
4.65%
Nach RegionUSD
Name
Umsatz
Anteil
United States
328.81M
100.00%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Pharmacy revenue
218.54M
66.46%
Commission
94.97M
28.88%
Production bonus and other revenue
15.30M
4.65%

Aktionärsstatistik

Aktualisiert: Mon, Nov 17
Aktualisiert: Mon, Nov 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Brookside Equity Partners LLC
10.03%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
4.59%
Abrams Bison Investments, L.L.C.
4.49%
Mariner Wealth Advisors
3.61%
Andere
72.17%
Aktionäre
Aktionäre
Anteil
Brookside Equity Partners LLC
10.03%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
4.59%
Abrams Bison Investments, L.L.C.
4.49%
Mariner Wealth Advisors
3.61%
Andere
72.17%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
20.37%
Investment Advisor/Hedge Fund
12.09%
Individual Investor
11.43%
Private Equity
10.03%
Hedge Fund
8.15%
Research Firm
2.10%
Corporation
0.62%
Pension Fund
0.28%
Bank and Trust
0.21%
Andere
34.72%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
334
93.80M
53.31%
-7.75M
2025Q3
327
94.38M
53.63%
-3.32M
2025Q2
332
110.44M
63.96%
+4.81M

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Brookside Equity Partners LLC
17.68M
10.05%
--
--
Sep 20, 2025
BlackRock Institutional Trust Company, N.A.
9.01M
5.12%
-200.07K
-2.17%
Sep 30, 2025
The Vanguard Group, Inc.
8.19M
4.65%
-20.74K
-0.25%
Sep 30, 2025
Abrams Bison Investments, L.L.C.
7.91M
4.5%
--
--
Sep 30, 2025
Mariner Wealth Advisors
6.37M
3.62%
+3.06K
+0.05%
Sep 30, 2025
Grant (William Thomas II)
4.66M
2.65%
+94.89K
+2.08%
Nov 12, 2024
Grant (Robert Clay)
4.32M
2.45%
--
--
Sep 20, 2025
Grant (William Thomas III)
4.20M
2.39%
--
--
Sep 20, 2025
Geode Capital Management, L.L.C.
3.33M
1.89%
+29.89K
+0.91%
Sep 30, 2025
State Street Investment Management (US)
2.96M
1.68%
-139.64K
-4.50%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Tue, Dec 2
Aktualisiert: Tue, Dec 2
Name
Anteil
iShares Micro-Cap ETF
0.06%
Fidelity Enhanced Small Cap ETF
0.04%
WisdomTree US SmallCap Quality Growth Fund
0.04%
Avantis US Small Cap Equity ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
Avantis US Small Cap Value ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Mehr Anzeigen
iShares Micro-Cap ETF
Anteil0.06%
Fidelity Enhanced Small Cap ETF
Anteil0.04%
WisdomTree US SmallCap Quality Growth Fund
Anteil0.04%
Avantis US Small Cap Equity ETF
Anteil0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.02%
Invesco RAFI US 1500 Small-Mid ETF
Anteil0.02%
ProShares Hedge Replication ETF
Anteil0.01%
iShares Russell 2000 ETF
Anteil0.01%
Avantis US Small Cap Value ETF
Anteil0.01%
Schwab U.S. Small-Cap ETF
Anteil0.01%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI